Moradinejad, Mehrnaz
Chaharmahali, Rayan
Shamohammadi, Milad
Mir, Maziar
Rakhshan, Vahid
Article History
Received: 25 December 2021
Accepted: 23 May 2022
First Online: 21 September 2022
Declarations
:
: M. Moradinejad, R. Chaharmahali, M. Shamohammadi, M. Mir and V. Rakhshan declare that they have no competing interests.
: Protocol ethics were approved before commencement in accordance with the Helsinki Declaration, by two review boards: the ethics committee of the Ahvaz Jundishapur University of Medical Sciences (ethical code: IR.AJUMS.REC.1399.612) and an international review board (RCT code: IRCT20201110049346N1 available at ExternalRef removed). Patients were thoroughly briefed and written consent forms were obtained from them. Patients could exit the study at any time, without discontinuing their treatment. <i>Consent for publication:</i> This paper does not include any images of any subjects or participants. All participants were consent to participate, and signed written agreements.